ライフサイエンスコーパス: alloimmunized

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 (15%) episodically transfused patients were alloimmunized.

2 14 (22%) of 64 patients (75% Asian) became alloimmunized.

3 on chronic RBC transfusion remained platelet-alloimmunized 11 to 22 months after initial testing.

4 patible red blood cells for patients who are alloimmunized against multiple antigens.

5 l of T cell polarization will differ between alloimmunized and non-alloimmunized SCD patients.

6 cyte transfusion recipients were found to be alloimmunized both to neutrophil-specific and HLA antige

7 CD4 and CD8 memory T cells were sorted from alloimmunized CXCR3 and wildtype B6 mice and cotransferr

8 KO mice lacking both FcgammaRs and C3 became alloimmunized despite immunoprophylaxis.

9 the peripheral blood lymphocytes of a single alloimmunized donor.

10 ma and apheresis platelets, from potentially alloimmunized donors, especially females.

11 or male recipients of a marrow graft from an alloimmunized female.

12 n-alloimmunized SCD patients, but not in the alloimmunized group.

13 D group, whereas it had little effect in the alloimmunized group.

14 re effective products for difficult, broadly alloimmunized individuals, including patients who have d

15 However, in alloimmunized lymphocytoxic antibody-positive patients,

16 e therefore reviewed the results of OAMPT to alloimmunized patients and assessed the relationship bet

17 ificant and can result in transplantation of alloimmunized patients considered to be non-sensitized.

18 platelet donor pool, significant numbers of alloimmunized patients have few if any available donors.

19 from nonmatched ABO compatible donors, while alloimmunized patients should receive granulocytes from

20 se data support extending donor searches for alloimmunized patients to include any single mismatch pa

21 er to determine platelet compatibility in 16 alloimmunized patients with aplastic anemia refractory t

22 level of LCTAB and the response of OAMPT to alloimmunized patients, 58% to 73% of recipients will ha

23 An approach more like that for red cell alloimmunized patients, in which one provides products g

24 These data suggest that unlike alloimmunized patients, non-alloimmunized SCD CD16+ mono

25 Originally designed for highly alloimmunized patients, this algorithm is based on the c

26 to refine and expand donor selection for HLA-alloimmunized patients.

27 vent fetal intracranial hemorrhage in HPA-1a alloimmunized pregnancies, we generated an antibody that

28 tly, the adoptive transfer of monocytes from alloimmunized RAG(-/-) mice conferred alloimmunity to na

29 l donors and by histocompatibility issues in alloimmunized recipients.

30 Non-alloimmunized SCD CD16+ monocytes expressed higher basal

31 gest that unlike alloimmunized patients, non-alloimmunized SCD CD16+ monocytes in response to transfu

32 reg/lower Th1) polarization state in the non-alloimmunized SCD group, whereas it had little effect in

33 hemin-treated stimulated monocytes from non-alloimmunized SCD patients, but not in the alloimmunized

34 on will differ between alloimmunized and non-alloimmunized SCD patients.

35 , 85% of heavily transfused SCD patients are alloimmunized to HLA and/or platelet-specific antigens.

36 Factors regulating which patients become alloimmunized to red blood cell (RBC) antigens are poorl

37 the policies of avoiding prospective donors alloimmunized to WBC antigens from donating plasma produ

38 onor specific antibody (DSA) in the serum of alloimmunized transplant patients with a failed renal gr

39 in two positive control donors who had been alloimmunized with Rh D-positive RBCs.

40 derived from an immortalized B cell from an alloimmunized woman who had an infant affected by FNAIT.

41 C terminus elicited proliferation in 90% of alloimmunized women, and it was confirmed that respondin

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。